RUBICON Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RUBICON, and what generic and branded alternatives to RUBICON drugs are available?
RUBICON has sixty-three approved drugs.
There is one tentative approval on RUBICON drugs.
Summary for RUBICON
| US Patents: | 0 |
| Tradenames: | 52 |
| Ingredients: | 52 |
| NDAs: | 63 |
Drugs and US Patents for RUBICON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | NORTRIPTYLINE HYDROCHLORIDE | nortriptyline hydrochloride | SOLUTION;ORAL | 217731-001 | Aug 15, 2023 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 078625-003 | Jan 27, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 208170-001 | May 31, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | GUANFACINE HYDROCHLORIDE | guanfacine hydrochloride | TABLET;ORAL | 216762-002 | Oct 17, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rubicon | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 215725-001 | Jul 25, 2022 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
